102 related articles for article (PubMed ID: 24948567)
1. Base-dependent formation of cis and trans olefins and their application in the synthesis of 5-oxo-ETE receptor antagonists.
Gore V; Chourey S; Ye Q; Patel P; Ouedraogo Y; Gravel S; Powell WS; Rokach J
Bioorg Med Chem Lett; 2014 Aug; 24(15):3385-8. PubMed ID: 24948567
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Metabolism of Selective Oxoeicosanoid (OXE) Receptor Antagonists and Their Effects on 5-Oxo-6,8,11,14-eicosatetraenoic Acid (5-Oxo-ETE)-Induced Granulocyte Activation in Monkeys.
Cossette C; Chourey S; Ye Q; Nagendra Reddy C; Gore V; Gravel S; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
J Med Chem; 2016 Nov; 59(22):10127-10146. PubMed ID: 27766872
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship study of β-oxidation resistant indole-based 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) receptor antagonists.
Ye Q; Chourey S; Wang R; Chintam NR; Gravel S; Powell WS; Rokach J
Bioorg Med Chem Lett; 2017 Oct; 27(20):4770-4776. PubMed ID: 28943042
[TBL] [Abstract][Full Text] [Related]
4. In vivo α-hydroxylation of a 2-alkylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid in monkeys.
Chourey S; Ye Q; Reddy CN; Cossette C; Gravel S; Zeller M; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
Biochem Pharmacol; 2017 Aug; 138():107-118. PubMed ID: 28476332
[TBL] [Abstract][Full Text] [Related]
5. 5-Oxo-ETE receptor antagonists.
Gore V; Patel P; Chang CT; Sivendran S; Kang N; Ouedraogo YP; Gravel S; Powell WS; Rokach J
J Med Chem; 2013 May; 56(9):3725-32. PubMed ID: 23581530
[TBL] [Abstract][Full Text] [Related]
6. Novel Highly Potent and Metabolically Resistant Oxoeicosanoid (OXE) Receptor Antagonists That Block the Actions of the Granulocyte Chemoattractant 5-Oxo-6,8,11,14-Eicosatetraenoic Acid (5-oxo-ETE).
Chourey S; Ye Q; Reddy CN; Wang R; Cossette C; Gravel S; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
J Med Chem; 2018 Jul; 61(14):5934-5948. PubMed ID: 29972644
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for activation of the 5-oxo-6E,8Z, 11Z,14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity.
Patel P; Cossette C; Anumolu JR; Gravel S; Lesimple A; Mamer OA; Rokach J; Powell WS
J Pharmacol Exp Ther; 2008 May; 325(2):698-707. PubMed ID: 18292294
[TBL] [Abstract][Full Text] [Related]
8. Targeting the OXE receptor as a potential novel therapy for asthma.
Powell WS; Rokach J
Biochem Pharmacol; 2020 Sep; 179():113930. PubMed ID: 32240653
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and pharmacokinetics of a potent N-acylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) in rats and monkeys.
Reddy CN; Alhamza H; Chourey S; Ye Q; Gore V; Cossette C; Gravel S; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
Eur J Pharm Sci; 2018 Mar; 115():88-99. PubMed ID: 29339225
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of 5-oxo-6,8,11,14-eicosatetraenoic acid-induced activation of neutrophils and eosinophils by novel indole OXE receptor antagonists.
Gore V; Gravel S; Cossette C; Patel P; Chourey S; Ye Q; Rokach J; Powell WS
J Med Chem; 2014 Jan; 57(2):364-77. PubMed ID: 24351031
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases.
Moreau A; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and biologic effects of 5-oxoeicosanoids on human neutrophils.
Powell WS; MacLeod RJ; Gravel S; Gravelle F; Bhakar A
J Immunol; 1996 Jan; 156(1):336-42. PubMed ID: 8598482
[TBL] [Abstract][Full Text] [Related]
13. 5-Oxo-ETE and the OXE receptor.
Grant GE; Rokach J; Powell WS
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):98-104. PubMed ID: 19450703
[TBL] [Abstract][Full Text] [Related]
14. From α-arylation of olefins to acylation with aldehydes: a journey in regiocontrol of the Heck reaction.
Ruan J; Xiao J
Acc Chem Res; 2011 Aug; 44(8):614-26. PubMed ID: 21612205
[TBL] [Abstract][Full Text] [Related]
15. Alkyl transfer from C-C cleavage: replacing the nitro group of nitro-olefins.
Li G; Wu L; Lv G; Liu H; Fu Q; Zhang X; Tang Z
Chem Commun (Camb); 2014 Jun; 50(47):6246-8. PubMed ID: 24789377
[TBL] [Abstract][Full Text] [Related]
16. 5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation.
Iikura M; Suzukawa M; Yamaguchi M; Sekiya T; Komiya A; Yoshimura-Uchiyama C; Nagase H; Matsushima K; Yamamoto K; Hirai K
J Allergy Clin Immunol; 2005 Sep; 116(3):578-85. PubMed ID: 16159627
[TBL] [Abstract][Full Text] [Related]
17. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration.
Powell WS; Chung D; Gravel S
J Immunol; 1995 Apr; 154(8):4123-32. PubMed ID: 7706749
[TBL] [Abstract][Full Text] [Related]
18. A highly tunable stereoselective olefination of semistabilized triphenylphosphonium ylides with N-sulfonyl imines.
Dong DJ; Li HH; Tian SK
J Am Chem Soc; 2010 Apr; 132(14):5018-20. PubMed ID: 20302297
[TBL] [Abstract][Full Text] [Related]
19. Novel highly potent OXE receptor antagonists with prolonged plasma lifetimes that are converted to active metabolites in vivo in monkeys.
Ye Q; Chourey S; Reddy CN; Wang R; Cossette C; Gravel S; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
Br J Pharmacol; 2020 Jan; 177(2):388-401. PubMed ID: 31655025
[TBL] [Abstract][Full Text] [Related]
20. Use of silver carbonate in the Wittig reaction.
Jedinak L; Rush L; Lee M; Hesek D; Fisher JF; Boggess B; Noll BC; Mobashery S
J Org Chem; 2013 Dec; 78(23):12224-8. PubMed ID: 24251875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
